BC Extra | Jan 17, 2020
Company News

Management tracks: Sun departs as Hengrui chair; plus Blackstone, Ipsen, bluebird, BioNTech, Catalent, Foundation, Twist, Lantheus, Abcam and more

Jiangsu Hengrui Medicine Co Ltd. (Shanghai:600276) said Piaoyang Sun will step down as chairman. Sun, who has led the company for 30 years, will continue to serve on the board’s strategy committee and is succeeded...
BC Extra | Nov 23, 2019
Company News

Management tracks: Sanofi head of strategy Mansuri set to retire; plus Arrakis, MorphoSys, Kymera, Kronos, Kite, Twist, Cerevel, Coda, Science 37, and more

Sanofi (Euronext:SAN; NASDAQ:SNY) said Muzammil Mansuri, EVP, head of strategy and business development, will retire at the end of the month. His responsibilities will be divided between Alban de La Sablière, head of business development,...
BC Extra | Nov 14, 2019
Company News

Management tracks: Longtime Abbott CEO resigning; plus Otsuka, Bavarian Nordic, Progenics and Rakuten

Miles White will step down as CEO of Abbott Laboratories (NYSE:ABT) on March 31, after 21 years in the role while remaining executive chairman. President and COO Robert Ford, who joined the company in 1996,...
BC Extra | Oct 2, 2019
Company News

Imaging company Lantheus enters therapeutics with Progenics takeout

Lantheus plans to acquire Progenics in an all-stock deal, creating a path for the medical imaging company to move into therapeutics. Based on the 86.4 million outstanding shares of Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) and the...
BC Innovations | May 28, 2019
Distillery Techniques

MRI detection of renal elastin to monitor kidney fibrosis

TECHNIQUES CATEGORY: Biomarkers; Imaging TECHNOLOGY: Tissue markers; MRI MRI detection of renal ELN could help monitor renal fibrosis in chronic kidney disease (CKD) patients. In kidney biopsy samples from CKD patients, ELN levels were higher...
BC Extra | Mar 26, 2019
Company News

Management tracks: Rubius, Abingworth, Arcus

Rubius hired Greg Whitehead as SVP and chief quality officer, a newly created position. He was VP, quality at bluebird bio Inc. (NASDAQ:BLUE). Whitehead will be responsible for defining the company's quality strategy to meet...
BC Extra | Feb 26, 2019
Company News

Management tracks: Immunomedics, Daiichi, Notable Labs

Immunomedics Inc. (NASDAQ:IMMU) said Michael Pehl resigned as president, CEO and a board member due to personal reasons, just 15 months after he joined the antibody-drug conjugate company. The news comes a month after FDA...
BC Extra | Aug 31, 2018
Company News

Management tracks: Medigene, Merck KGaA

Medigene AG (Xetra:MDG1) said CFO Thomas Taapken has resigned. Medigene is seeking a successor. Taapken, who joined the cancer immunotherapy company in January 2017, will continue to advise Medigene as a consultant through the end...
BC Extra | Aug 21, 2018
Company News

Management tracks: HBP parts ways with Executive Director Chris Ebell

The Human Brain Project (HBP) said Executive Director and Head of the Project Coordination Office Chris Ebell has resigned "following a change of university leadership and differences of opinion on governance and on strategic orientations...
BC Week In Review | Mar 31, 2017
Financial News

Lantheus completes debt financing

On March 30, diagnostics and imaging company Lantheus Holdings Inc. (NASDAQ:LNTH) raised $275 million in a term loan. The loan bears interest at Lantheus’ option of 4.5% plus LIBOR or 3.5% plus the base rate...
Items per page:
1 - 10 of 77
BC Extra | Jan 17, 2020
Company News

Management tracks: Sun departs as Hengrui chair; plus Blackstone, Ipsen, bluebird, BioNTech, Catalent, Foundation, Twist, Lantheus, Abcam and more

Jiangsu Hengrui Medicine Co Ltd. (Shanghai:600276) said Piaoyang Sun will step down as chairman. Sun, who has led the company for 30 years, will continue to serve on the board’s strategy committee and is succeeded...
BC Extra | Nov 23, 2019
Company News

Management tracks: Sanofi head of strategy Mansuri set to retire; plus Arrakis, MorphoSys, Kymera, Kronos, Kite, Twist, Cerevel, Coda, Science 37, and more

Sanofi (Euronext:SAN; NASDAQ:SNY) said Muzammil Mansuri, EVP, head of strategy and business development, will retire at the end of the month. His responsibilities will be divided between Alban de La Sablière, head of business development,...
BC Extra | Nov 14, 2019
Company News

Management tracks: Longtime Abbott CEO resigning; plus Otsuka, Bavarian Nordic, Progenics and Rakuten

Miles White will step down as CEO of Abbott Laboratories (NYSE:ABT) on March 31, after 21 years in the role while remaining executive chairman. President and COO Robert Ford, who joined the company in 1996,...
BC Extra | Oct 2, 2019
Company News

Imaging company Lantheus enters therapeutics with Progenics takeout

Lantheus plans to acquire Progenics in an all-stock deal, creating a path for the medical imaging company to move into therapeutics. Based on the 86.4 million outstanding shares of Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) and the...
BC Innovations | May 28, 2019
Distillery Techniques

MRI detection of renal elastin to monitor kidney fibrosis

TECHNIQUES CATEGORY: Biomarkers; Imaging TECHNOLOGY: Tissue markers; MRI MRI detection of renal ELN could help monitor renal fibrosis in chronic kidney disease (CKD) patients. In kidney biopsy samples from CKD patients, ELN levels were higher...
BC Extra | Mar 26, 2019
Company News

Management tracks: Rubius, Abingworth, Arcus

Rubius hired Greg Whitehead as SVP and chief quality officer, a newly created position. He was VP, quality at bluebird bio Inc. (NASDAQ:BLUE). Whitehead will be responsible for defining the company's quality strategy to meet...
BC Extra | Feb 26, 2019
Company News

Management tracks: Immunomedics, Daiichi, Notable Labs

Immunomedics Inc. (NASDAQ:IMMU) said Michael Pehl resigned as president, CEO and a board member due to personal reasons, just 15 months after he joined the antibody-drug conjugate company. The news comes a month after FDA...
BC Extra | Aug 31, 2018
Company News

Management tracks: Medigene, Merck KGaA

Medigene AG (Xetra:MDG1) said CFO Thomas Taapken has resigned. Medigene is seeking a successor. Taapken, who joined the cancer immunotherapy company in January 2017, will continue to advise Medigene as a consultant through the end...
BC Extra | Aug 21, 2018
Company News

Management tracks: HBP parts ways with Executive Director Chris Ebell

The Human Brain Project (HBP) said Executive Director and Head of the Project Coordination Office Chris Ebell has resigned "following a change of university leadership and differences of opinion on governance and on strategic orientations...
BC Week In Review | Mar 31, 2017
Financial News

Lantheus completes debt financing

On March 30, diagnostics and imaging company Lantheus Holdings Inc. (NASDAQ:LNTH) raised $275 million in a term loan. The loan bears interest at Lantheus’ option of 4.5% plus LIBOR or 3.5% plus the base rate...
Items per page:
1 - 10 of 77